Vasopressor Agents in Pulmonary Hypertension Crisis

Starting soon · Not applicable

Conditions studied: Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Hypertension, Pulmonary

In brief

Comparison of the efficacy and safety of three vasoactive agents-dopamine, norepinephrine, and epinephrine-in the treatment of patients with pulmonary hypertension crisis: prospective, randomised controlled trial monitored by haemodynamic monitoring

Key facts

Study ID
NCT07667829
Run by
China National Center for Cardiovascular Diseases
People needed
75
Starts
2026-06-01
Expected to finish
2029-01-31
Last updated by the study team
2026-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.